Skip to main content
. 2018 Feb 6;13(2):e0192243. doi: 10.1371/journal.pone.0192243

Table 2. Sensitivity analysis.

Outcomes Excluding study OR and 95% CI P value Heterogeneity (%) P value for heterogeneity
30-day survival rate Shaw 2006 1.69 (0.95–3.03) 0.076 0.0 0.955
Mathus-Vliegen 1994 1.49 (0.84–2.65) 0.168 0.0 0.957
Mazzini 1995 1.58 (0.91–2.73) 0.105 0.0 0.935
Spataro 2011 1.59 (0.93–2.71) 0.092 0.0 0.966
Blondet 2010 1.65 (0.95–2.87) 0.078 0.0 0.951
Thornton 2002 1.55 (0.89–2.68) 0.120 0.0 0.947
Allen 2013 1.55 (0.86–2.79) 0.141 0.0 0.937
Desport 2005 1.71 (0.98–3.00) 0.060 0.0 0.979
ProGas Study Group 2015 1.41 (0.76–2.61) 0.278 0.0 0.969
Chio 2004 1.64 (0.94–2.86) 0.080 0.0 0.949
10-month survival rate Shaw 2006 1.25 (0.65–2.39) 0.500 55.5 0.028
Mathus-Vliegen 1994 1.28 (0.69–2.39) 0.434 54.9 0.030
Mazzini 1995 1.17 (0.61–2.24) 0.641 54.7 0.031
Spataro 2011 1.25 (0.69–2.25) 0.458 55.5 0.028
Blondet 2010 1.12 (0.62–2.02) 0.709 50.0 0.051
Thornton 2002 1.09 (0.64–1.87) 0.741 41.8 0.100
Desport 2005 1.44 (0.81–2.53) 0.212 44.6 0.082
ProGas Study Group 2015 1.18 (0.56–2.51) 0.660 56.2 0.025
Chio 2004 1.38 (0.91–2.10) 0.125 20.2 0.269
20-month survival rate Shaw 2006 1.94 (1.16–3.26) 0.012 0.0 0.490
Mathus-Vliegen 1994 2.04 (1.22–3.40) 0.006 0.0 0.514
Mazzini 1995 1.68 (0.99–2.85) 0.055 0.0 0.832
Spataro 2011 2.13 (1.16–3.92) 0.015 0.0 0.510
Blondet 2010 1.86 (1.11–3.12) 0.018 0.0 0.545
Thornton 2002 2.02 (1.20–3.39) 0.008 0.0 0.497
Desport 2005 2.18 (1.31–3.62) 0.003 0.0 0.762
30-month survival rate Shaw 2006 1.25 (0.74–2.10) 0.409 0.0 0.928
Mathus-Vliegen 1994 1.28 (0.76–2.17) 0.352 0.0 0.913
Spataro 2011 1.34 (0.61–2.97) 0.463 0.0 0.917
Blondet 2010 1.22 (0.73–2.03) 0.451 0.0 0.993
Thornton 2002 1.32 (0.77–2.23) 0.310 0.0 0.929
Desport 2005 1.30 (0.77–2.18) 0.320 0.0 0.923

*OR, odds ratio; CI, confidence interval